Thermostable FGF2 Polypeptide, Use Thereof

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F21%3A00121632" target="_blank" >RIV/00216224:14310/21:00121632 - isvavai.cz</a>

Result on the web

<a href="http://is.muni.cz/publication/1770461/40469SG2-CERT.PDF" target="_blank" >http://is.muni.cz/publication/1770461/40469SG2-CERT.PDF</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Thermostable FGF2 Polypeptide, Use Thereof

Original language description

The invention provides an isolated thermostable polypeptide possessing FGF2 activity and having at least 85% sequence identity to SEQ ID NO: 2 (FGF2 wt) or a functional fragment thereof, and comprising at least one amino acid substitution R31L and the use thereof in the cell biology research, regenerative medicine and related medical applications or cosmetics. Further it discloses a culture medium comprising subjected FGF2 suitable for culturing a human pluripotent stem cells involving both human embryonic stem cells and induced pluripotent stem cells.

Czech name

—

Czech description

—

Type

P - Patent

CEP classification

—

OECD FORD branch

10600 - Biological sciences

Project

<a href="/en/project/LO1214" target="_blank" >LO1214: Research Centre for Toxic Compounds in the Environment</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2021

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Patent/design ID

SG11201804402W

Publisher

SG001 -

Publisher name

Intellectual Property Office of Singapore (IPOS)

Place of publication

Singapore

Publication country

SG - SINGAPORE

Date of acceptance

Apr 5, 2021

Owner name

Masarykova univerzita; Enantis s.r.o.

Method of use

A - Výsledek využívá pouze poskytovatel

Usage type

A - K využití výsledku jiným subjektem je vždy nutné nabytí licence